We are spending countless hours on electronic health records scrolling through layers of data to find the information we need, receiving vital information through fax machines, and listening to ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

One way to vet an algorithm, the Journal of the American Medicine Informatics Association paper suggests, would be to send a ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Nuclear medicine has made significant strides in the field of oncology ... All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as ...

Dhruv Srinivasachar, MD, earned his medical degree from Virginia Commonwealth University in Richmond, Va., and is a PGY-4 ...

Pilot medical apprenticeship programmes in England, which were being trialled as a new route into the profession, have been paused by the government. Peninsula Medical School in Plymouth, one of the ...

It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another ...

A more granular classification of patients based on inflammation-related molecular signatures can pave the way for precision ...

China's scientific journals have made significant strides in their academic influence and quality improvements over the past decade, according to the Blue Book on China's Scientific Journal ...

In a scathing op-ed the Journal, whose parent company Dow Jones is owned by Rupert Murdoch’s News Corp, said that Trump “on the advice of Elon Musk blew up the end-of-session budget bill ...

Ongoing and future clinical trials with cetuximab will be limited to enrolling patients with KRAS wild-type tumours, thereby increasing the possibility of demonstrating benefit from the drug by ...